Position in GRFS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,721,963
-$11,156,879 QoQ
Shares Held
808,187
-61.6% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 164 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $8,073,972,287 across 18 Drug Manufacturers - General names. GRFS ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,143,891 | $1,372,017,294 | |
| 2 | ABBV |
AbbVie Inc.
|
5,015,515 | $1,262,104,193 | |
| 3 | AZN |
Astrazeneca PLC
|
6,592,403 | $1,250,051,454 | |
| 4 | JNJ |
Johnson & Johnson
|
4,651,595 | $1,181,365,579 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,793,897 | $873,015,763 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,113,242 | $646,006,993 | |
| 7 | AMGN |
Amgen Inc
|
1,326,673 | $480,414,824 | |
| 8 | PFE |
Pfizer Inc
|
16,746,801 | $403,262,965 |
All Filings in GRFS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,721,963 | 808,187 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $16,878,842 | 2,104,594 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,763,846 | 2,434,636 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,426,654 | 1,046,853 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $1,150,538 | 127,272 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $605,594 | 85,175 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $620,629 | 83,418 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $5,261,860 | 592,552 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $777,082 | 123,151 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $3,823,056 | 572,314 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $4,416,000 | 382,007 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $93,400 | 10,219 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $297,159 | 32,441 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $1,122,723 | 152,337 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $608,667 | 71,608 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $5,769,689 | 936,638 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,686,959 | 142,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $8,386,461 | 718,019 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $497,196 | 44,274 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,173,645 | 148,778 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,595,505 | 91,960 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,256,863 | 130,530 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $12,612 | 684 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,927 | 284 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,180 | 284 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $503,500 | 25,000 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||